SCHEMBL9008929

SCHEMBL9008929

CCCCCCCCCCCC(OP(=O)(O)OP(=O)(O)O)C(O)[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1O

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.51
TK1 P04183 8/20 0.50
POLA1 P09884 1/20 0.46
POLD1 P28340 1/20 0.46
TK2 O00142 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9008931 1.00 POLB (0.51) POLBTK1POLA1POLD1TK2
SCHEMBL6910401 0.80 POLB (0.54) POLBTK1POLA1POLD1
SCHEMBL10684890 0.80 POLB (0.54) POLBTK1POLA1POLD1
SCHEMBL7201324 0.78 TK1 (0.60) POLBTK1
SCHEMBL9008859 0.78 POLG (0.51) POLB
SCHEMBL9008942 0.78 POLG (0.51) POLB
SCHEMBL5358020 0.77 TK2 (0.55) TK1TK2
SCHEMBL5372684 0.77 TK2 (0.55) TK1TK2
SCHEMBL7525577 0.77 TK1 (0.61) POLBTK1
SCHEMBL27984187 0.77 TK1 (0.61) POLBTK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0738274-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) 1996-10-23 EP claimed
WO-1995018816-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE Max-Delbrück-Centrum für Molekulare Medizin (DE) 1995-07-13 WO claimed
EP-0738274-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) 1996-10-23 EP disclosed
WO-1995018816-A1 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE Max-Delbrück-Centrum für Molekulare Medizin (DE) 1995-07-13 WO disclosed